Agios Pharmaceuticals, Inc. AGIO
995 filings, 7 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 55 events
- Nov 5, 2026 Planned sale James Burns (Chief Legal Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 19,754 shares, runs to Dec 10, 2027
- Nov 5, 2026 8-K Quarterly results8-K item 2.02
- Nov 5, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 26, 2026 Planned sale SARAH GHEUENS (Officer) gave notice of a planned sale of 7,866 shares worth about $296KForm 144, approximate sale date Oct 26, 2026, under a 10b5-1 plan adopted May 1, 2026
- Oct 22, 2026 Planned sale SARAH GHEUENS (Officer) gave notice of a planned sale of 500 shares worth about $19KForm 144, approximate sale date Oct 22, 2026, under a 10b5-1 plan adopted May 1, 2026
- Oct 21, 2026 Planned sale SARAH GHEUENS (Officer) gave notice of a planned sale of 1,489 shares worth about $56KForm 144, approximate sale date Oct 21, 2026, under a 10b5-1 plan adopted May 1, 2026
- Aug 4, 2026 Planned sale SARAH GHEUENS (Officer) gave notice of a planned sale of 30,000 shares worth about $914KForm 144, approximate sale date Aug 4, 2026, under a 10b5-1 plan adopted May 1, 2026
- Jul 30, 2026 Planned sale Cecilia Jones (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 34,076 shares, runs to Aug 2, 2027
- Jul 30, 2026 Planned sale Sarah Gheuens, M.D., Ph.D. (Chief Medical Officer, Head of Research & Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 151,653 shares, runs to Aug 2, 2027
- Jul 30, 2026 Planned sale Tsveta Milanova (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 9,403 shares, runs to Jul 30, 2027
- Jul 30, 2026 8-K Quarterly results8-K item 2.02
- Jul 30, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 1, 2026 Planned sale Gheuens Sarah (Officer) gave notice of a planned sale of 4,007 shares worth about $151KForm 144, approximate sale date Jul 1, 2026, under a 10b5-1 plan adopted Jul 1, 2023
- Jun 18, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- Apr 29, 2026 8-K Quarterly results8-K item 2.02
- Apr 29, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 2, 2026 Planned sale Burns James William (Officer) gave notice of a planned sale of 3,280 shares worth about $112KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted Mar 1, 2024
- Apr 2, 2026 Planned sale Gheuens Sarah (Officer) gave notice of a planned sale of 2,940 shares worth about $101KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted Mar 1, 2024
- Apr 2, 2026 Planned sale Milanova Tsveta (Officer) gave notice of a planned sale of 3,262 shares worth about $112KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted Mar 1, 2024
- Apr 2, 2026 Planned sale Viswanadhan Krishnan (Officer) gave notice of a planned sale of 2,959 shares worth about $101KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted Mar 5, 2025
- Apr 2, 2026 Planned sale Jones Cecilia (Officer) gave notice of a planned sale of 3,141 shares worth about $107KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted Mar 1, 2024
- Apr 2, 2026 Planned sale Goff Brian (Officer, Director) gave notice of a planned sale of 19,068 shares worth about $652KForm 144, approximate sale date Apr 2, 2026, under a 10b5-1 plan adopted Aug 8, 2022
- Mar 5, 2026 Planned sale Viswanadhan Krishnan (Officer) gave notice of a planned sale of 2,959 shares worth about $86KForm 144, approximate sale date Mar 5, 2026, under a 10b5-1 plan adopted Mar 5, 2025
- Mar 2, 2026 Planned sale Milanova Tsveta (Officer) gave notice of a planned sale of 2,868 shares worth about $87KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Mar 1, 2025
- Mar 2, 2026 Planned sale Jones Cecilia (Officer) gave notice of a planned sale of 5,035 shares worth about $152KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Mar 1, 2025
- Mar 2, 2026 Planned sale Gheuens Sarah (Officer) gave notice of a planned sale of 4,055 shares worth about $123KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Mar 1, 2025
- Mar 2, 2026 Planned sale Burns James William (Officer) gave notice of a planned sale of 5,218 shares worth about $158KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Mar 1, 2025
- Mar 2, 2026 Planned sale Goff Brian (Officer, Director) gave notice of a planned sale of 18,055 shares worth about $546KForm 144, approximate sale date Mar 2, 2026, under a 10b5-1 plan adopted Mar 1, 2025
- Feb 12, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · We may offer and sell securities from time to time in one or more offerings.
- Feb 12, 2026 8-K Quarterly results8-K item 2.02
- Feb 12, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Jan 12, 2026 8-K Regulation FD disclosure8-K item 7.01
- Jan 5, 2026 Planned sale Milanova Tsveta (Officer) gave notice of a planned sale of 2,872 shares worth about $78KForm 144, approximate sale date Jan 5, 2026, under a 10b5-1 plan adopted Jan 3, 2023
- Dec 30, 2025 Planned sale Burns James William (Officer) gave notice of a planned sale of 2,932 shares worth about $80KForm 144, approximate sale date Dec 30, 2025, under a 10b5-1 plan adopted Mar 1, 2023
- Dec 30, 2025 Planned sale Milanova Tsveta (Officer) gave notice of a planned sale of 2,932 shares worth about $80KForm 144, approximate sale date Dec 30, 2025, under a 10b5-1 plan adopted Mar 1, 2023
- Dec 30, 2025 Planned sale Jones Cecilia (Officer) gave notice of a planned sale of 2,932 shares worth about $80KForm 144, approximate sale date Dec 30, 2025, under a 10b5-1 plan adopted Mar 1, 2023
- Dec 30, 2025 Planned sale Gheuens Sarah (Officer) gave notice of a planned sale of 2,932 shares worth about $80KForm 144, approximate sale date Dec 30, 2025, under a 10b5-1 plan adopted Mar 1, 2023
- Dec 30, 2025 Planned sale Goff Brian (Officer, Director) gave notice of a planned sale of 18,703 shares worth about $508KForm 144, approximate sale date Dec 30, 2025, under a 10b5-1 plan adopted Aug 8, 2022
- Oct 30, 2025 8-K Quarterly results8-K item 2.02
- Oct 30, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Aug 4, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jul 31, 2025 8-K Quarterly results8-K item 2.02
- Jul 31, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 8, 2025 8-K Director or officer change8-K item 5.02
- Jun 18, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 1, 2025 Planned sale Sarah Gheuens, M.D., Ph.D. (Chief Medical Officer, Head of Research & Development) adopted a 10b5-1 trading planreported in the 10-Q, up to 98,067 shares, runs to May 27, 2026
- May 1, 2025 8-K Quarterly results8-K item 2.02
- May 1, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Feb 13, 2025 Planned sale Cecilia Jones (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 24,779 shares, runs to Mar 17, 2026
- Feb 13, 2025 Planned sale Tsveta Milanova (Chief Commercial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 18,831 shares, runs to Mar 17, 2026
- Feb 13, 2025 8-K Director or officer change8-K item 5.02
- Feb 13, 2025 8-K Quarterly results8-K item 2.02
- Feb 13, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 13, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jan 6, 2025 8-K Regulation FD disclosure8-K item 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly report |
| Nov 5, 2026 | 8-K | Quarterly results |
| Oct 28, 2026 | 4 | Insider trade |
| Oct 26, 2026 | 144 | Notice of planned insider sale |
| Oct 23, 2026 | 4 | Insider trade |
| Oct 22, 2026 | 144 | Notice of planned insider sale |
| Oct 21, 2026 | 144 | Notice of planned insider sale |
| Aug 6, 2026 | 4 | Insider trade |
| Aug 4, 2026 | 144 | Notice of planned insider sale |
| Aug 3, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 30, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 8-K | Quarterly results |
| Jul 10, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Jul 1, 2026 | 144 | Notice of planned insider sale |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 23, 2026 | 4 | Insider trade |
| Jun 18, 2026 | S-8 | Shares registered for employee plans |
| Jun 18, 2026 | 8-K | Director or officer change, Shareholder vote results |
| Jun 16, 2026 | 4 | Insider trade |
| Jun 16, 2026 | 4 | Insider trade |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 6, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | 10-Q | Quarterly report |
| Apr 29, 2026 | 8-K | Quarterly results |
| Apr 24, 2026 | ARS | Annual report to shareholders |
| Apr 24, 2026 | DEFA14A | Extra proxy material |
| Apr 24, 2026 | DEF 14A | Proxy statement |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 6, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 144 | Notice of planned insider sale |
| Apr 2, 2026 | 144 | Notice of planned insider sale |
| Apr 2, 2026 | 144 | Notice of planned insider sale |
| Apr 2, 2026 | 144 | Notice of planned insider sale |
| Apr 2, 2026 | 144 | Notice of planned insider sale |
| Apr 2, 2026 | 144 | Notice of planned insider sale |
| Mar 26, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 9, 2026 | 4 | Insider trade |
| Mar 5, 2026 | 144 | Notice of planned insider sale |
| Mar 5, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Mar 2, 2026 | 144 | Notice of planned insider sale |
| Feb 17, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Feb 12, 2026 | 10-K | Annual report |
| Feb 12, 2026 | 8-K | Quarterly results |
| Feb 12, 2026 | S-3ASR | Shelf registration |
| Feb 9, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jan 12, 2026 | 8-K | Regulation FD disclosure |
| Jan 7, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 144 | Notice of planned insider sale |
| Jan 2, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 4 | Insider trade |
| Jan 2, 2026 | 4 | Insider trade |
| Dec 30, 2025 | 144 | Notice of planned insider sale |
| Dec 30, 2025 | 144 | Notice of planned insider sale |
| Dec 30, 2025 | 144 | Notice of planned insider sale |
| Dec 30, 2025 | 144 | Notice of planned insider sale |
| Dec 30, 2025 | 144 | Notice of planned insider sale |
| Dec 5, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 14, 2025 | 4 | Insider trade |
| Nov 14, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 13, 2025 | 4 | Insider trade |
| Nov 12, 2025 | 144 | Notice of planned insider sale |
| Nov 3, 2025 | 4 | Insider trade |
| Oct 30, 2025 | 144 | Notice of planned insider sale |
| Oct 30, 2025 | 10-Q | Quarterly report |
| Oct 30, 2025 | 8-K | Quarterly results |
| Oct 29, 2025 | 4 | Insider trade |
| Oct 27, 2025 | 144 | Notice of planned insider sale |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AGIO/export.csv") into a cell.